Ipamorelin Peptide Therapy
Ipamorelin is a selective growth hormone-releasing peptide (GHRP). Researched for its ability to stimulate GH release without notably affecting cortisol or prolactin levels.
/)
/)
What Ipamorelin may support
Ipamorelin is often described as the gentlest GH releaser, with minimal effect on cortisol, prolactin, or hunger signaling. Common in protocols where a lighter touch on the pituitary is preferred.
Our team evaluates suitability case-by-case, often pairing Ipamorelin with a GHRH peptide for synergistic effect, and tracking IGF-1 over the protocol.
Patient experiences
Wanted a softer GH protocol. The doctor scoped Ipamorelin alongside Sermorelin with light bedtime dosing. Sleep quality picked up first.
Tried other GH support that messed with appetite. Ipamorelin avoided that. Clear win for me.
Eight-week cycle with labs front and back. Felt informed every step.
Our solutions for Weight‑Loss Management
What BPC-157 is studied for
Indications evaluated in research, listed in order of current evidence weight. Suitability is determined case-by-case.
/)
What is Ipamorelin?
Ipamorelin is a selective growth hormone-releasing peptide (GHRP). Researched for its ability to stimulate GH release without notably affecting cortisol or prolactin levels.
/)
How Ipamorelin may work
Ipamorelin acts on the ghrelin receptor in the pituitary, triggering GH release without the cortisol or prolactin elevation seen with older GHRPs. The receptor selectivity is what makes it 'gentle'.
/)
Who it may be evaluated for
Adults seeking GH support with minimal pituitary load, often as part of a stacked protocol. Doctor screens for suitability via labs and goals.
/)
How Menscape prescribes Ipamorelin
Typically combined with a GHRH peptide (Sermorelin or CJC-1295) for synergistic effect. Bedtime subcutaneous dosing, 8 to 16 week cycles, with IGF-1 monitoring.
Doctor-led evaluation
Every Ipamorelin protocol starts with a full medical consultation and history review.
Licensed compounding pharmacy
Prescriptions are filled by a licensed compounding pharmacy partner, not over-the-counter.
Monthly monitoring
Follow-up consultations every four to six weeks to assess response and safety.
Research-informed positioning
We frame Ipamorelin as a research-stage peptide and prescribe only when clinically appropriate.
Ipamorelin questions
How is Ipamorelin different from Sermorelin?
Ipamorelin is a GHRP (ghrelin pathway); Sermorelin is a GHRH analog. They work on different receptors and are often used together.
Will Ipamorelin make me hungry?
Unlike older GHRPs (GHRP-6), Ipamorelin has minimal effect on appetite. This is one of the reasons it's preferred.
Is Ipamorelin FDA-approved?
No. Ipamorelin is a research peptide. Use is off-label and doctor-supervised.
How long are typical protocols?
8 to 16 weeks, often as part of a longer rotation. The doctor tailors based on labs and response.
Can Ipamorelin be combined with TRT?
Often yes. Ipamorelin supports endogenous GH release while TRT replaces testosterone — they act on different axes. Your doctor reviews labs to confirm both are appropriate.
What follow-up is included?
IGF-1 is rechecked at 8 to 12 weeks, with a clinical review covering sleep, recovery, body composition, and any side effects. Protocol adjustments are made based on response.
Talk with our medical team about BPC-157
/)